Intervention Protocol

Antibiotics for neonates born through meconium stained amniotic fluid

  1. Sandesh Shivananda1,*,
  2. Prashanth Murthy2,
  3. Prakeshkumar S Shah3

Editorial Group: Cochrane Neonatal Group

Published Online: 18 OCT 2006

Assessed as up-to-date: 16 JUN 2006

DOI: 10.1002/14651858.CD006183


How to Cite

Shivananda S, Murthy P, Shah PS. Antibiotics for neonates born through meconium stained amniotic fluid (Protocol). Cochrane Database of Systematic Reviews 2006, Issue 4. Art. No.: CD006183. DOI: 10.1002/14651858.CD006183.

Author Information

  1. 1

    McMaster Children's Hospital, Division of Neonatology, Hamilton, Ontario, Canada

  2. 2

    Mount Sinai Hospital and Fellowship in Neonatal Perinatal Medicine, Department of Paediatrics, Toronto, Ontario, Canada

  3. 3

    University of Toronto, Department of Paediatrics and Department of Health Policy, Management and Evaluation, Rm 775A, Toronto, Ontario, Canada

*Sandesh Shivananda, Division of Neonatology, McMaster Children's Hospital, 1200 Main Street West, Hamilton, Ontario, L8N 3Z5, Canada. shivan@mcmaster.ca.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 18 OCT 2006

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

The objectives of this review will be to assess the role of antibiotics for:
i) Prevention of infectious morbidity and mortality in infants born through MSAF and are asymptomatic at birth
ii) Prevention of infectious morbidity and mortality in infants born through MSAF who have signs and symptoms compatible with MAS